| Clofarabine studied in …STUDIED_INderived132 of 132show fewer |
|---|
| → studied in | NCT01188174Phase 2 · completed Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01885689Phase 2 · active not recruiting Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia · 132 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome,Secondary Myelodysplastic Syndrome,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03136146Phase 2 · recruiting Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Burkitt Leukemia,Lymphoblastic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04994808Phase 2 · terminated Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia · 132 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02727803Phase 2 · recruiting Personalized NK Cell Therapy in CBT · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03117751Phase 2/Phase 3 · active not recruiting Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02883049Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations · 132 trials list this drug (9 active) | — | — | Central Nervous System Leukemia,Testicular Leukemia,B Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07566377Phase 2 · recruiting Cord Blood Transplantation in Children and Young Adults With Blood Cancer · 132 trials list this drug (9 active) | — | — | Leukemia,Lymphoma,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01279096Phase 1 · completed Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia · 132 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644016Phase 2 · recruiting Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05917405Phase 2 · recruiting Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06252870Phase 2 · recruiting Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation · 132 trials list this drug (9 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07034053Phase 1/Phase 2 · recruiting Clofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma · 132 trials list this drug (9 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03615105Phase 2 · terminated Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01701986Phase 1/Phase 2 · completed Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma · 132 trials list this drug (9 active) | — | — | B-Cell Non-Hodgkin Lymphoma,Hodgkin Lymphoma,T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02085408Phase 3 · completed Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · 132 trials list this drug (9 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01228331Phase 2/Phase 3 · completed Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05569512Phase 1 · terminated Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML · 132 trials list this drug (9 active) | — | — | Childhood Malignant Neoplasm,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02135874Phase 2 · completed Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia · 132 trials list this drug (9 active) | — | — | Acute Leukemia of Ambiguous Lineage,Acute Undifferentiated Leukemia,Mixed Phenotype Acute Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02441803Phase 2 · completed Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01041508Phase 1 · completed Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia. · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04220008Phase 2 · withdrawn Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma · 132 trials list this drug (9 active) | — | — | B-Cell Non-Hodgkin Lymphoma,T-Cell Non-Hodgkin Lymphoma,Transformed B-Cell Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00697684Phase 1 · completed Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04989335Phase 2 · unknown Bisantrene Combination for Resistant AML · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096782Phase 2 · completed Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma · 132 trials list this drug (9 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04002115Phase 2 · terminated Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00641030Phase 1 · completed Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes · 132 trials list this drug (9 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00644189Phase 1/Phase 2 · completed Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma · 132 trials list this drug (9 active) | — | — | Anaplastic Large Cell Lymphoma,Small Lymphocytic Lymphoma,Diffuse Large B-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00423514Phase 1/Phase 2 · completed Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease · 132 trials list this drug (9 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01842672Phase 1/Phase 2 · completed Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Burkitt Leukemia,Lymphoblastic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01700946Phase 2 · completed Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma · 132 trials list this drug (9 active) | — | — | Childhood B Acute Lymphoblastic Leukemia,Childhood B Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01119066Phase 2 · completed HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Multiple Myeloma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01451515Phase 2 · completed NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma · 132 trials list this drug (9 active) | — | — | Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042341Phase 2 · completed Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL) · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416351Phase 1/Phase 2 · completed Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment · 132 trials list this drug (9 active) | — | — | Leukemia,Lymphoma,Small Intestinal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00531232Phase 2 · completed A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS) · 132 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02083250Phase 1 · completed Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01471444Phase 3 · completed Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01158885Phase 2 · terminated Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03609814completed Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT) · 132 trials list this drug (9 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00703820Phase 3 · completed Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00469014Phase 2 · completed Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia · 132 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00983528Phase 1/Phase 2 · terminated Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01252667Phase 2 · completed Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00857389Phase 2 · completed Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies · 132 trials list this drug (9 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02349178Phase 2 · terminated Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00498316Phase 1 · completed Cord Blood Expansion on Mesenchymal Stem Cells · 132 trials list this drug (9 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01596699Phase 2 · terminated Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation · 132 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01289457Phase 1/Phase 2 · completed Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01629511Phase 1/Phase 2 · terminated Allogeneic Stem Cell Transplant for CLL · 132 trials list this drug (9 active) | — | — | Chronic Lymphocytic Leukemia,Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00939653Phase 2 · terminated T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML) · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01629082Phase 1 · completed Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia · 132 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00691652Phase 1/Phase 2 · terminated Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma · 132 trials list this drug (9 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01160354Phase 1/Phase 2 · terminated Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML) · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00882076Phase 1 · terminated Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01794702Phase 1/Phase 2 · completed Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02518750Phase 2 · terminated Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma · 132 trials list this drug (9 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01031368Phase 1 · completed Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia · 132 trials list this drug (9 active) | — | — | Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with Maturation+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00903760Phase 2 · completed Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS) · 132 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00065143Phase 2 · completed Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome · 132 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome,Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01025154Phase 2 · completed Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01422603Phase 1/Phase 2 · completed Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML) · 132 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00295841Phase 1 · completed Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00990249Phase 2 · completed Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation · 132 trials list this drug (9 active) | — | — | Leukemia,Lymphoma,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01444742Phase 2 · completed Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) · 132 trials list this drug (9 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00602225Phase 1/Phase 2 · completed Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00852709Phase 1 · terminated Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias · 132 trials list this drug (9 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00908167Phase 1 · completed Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies · 132 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00617929Phase 2 · terminated Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant · 132 trials list this drug (9 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00201669Phase 2 · completed A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma · 132 trials list this drug (9 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01677949Phase 2 · withdrawn Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00156013Phase 1/Phase 2 · completed Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL) · 132 trials list this drug (9 active) | — | — | B-Cell Malignant Neoplasm,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00775593Phase 2 · completed Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00945815Phase 2 · completed S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01101880Phase 2 · completed Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm · 132 trials list this drug (9 active) | — | — | Chronic Myelomonocytic Leukemia,Myelodysplastic Syndrome with Excess Blasts,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01169012Phase 1 · completed PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01643668Phase 2 · completed Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00839982Phase 1/Phase 2 · completed Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS · 132 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome,Adult Acute Myeloid Leukemia,Myelodysplastic Syndrome with del(5q)+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01656031Phase 2 · completed A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00372619Phase 1/Phase 2 · completed Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00708721Phase 1/Phase 2 · terminated Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia · 132 trials list this drug (9 active) | — | — | Malignant Neoplasm,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00863434Phase 2 · terminated Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual Disease · 132 trials list this drug (9 active) | — | — | Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01471067Phase 1 · completed Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies · 132 trials list this drug (9 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00973752Phase 2 · completed Treatment of Older Adults With Acute Lymphoblastic Leukemia · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01900509Phase 1 · completed Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies · 132 trials list this drug (9 active) | — | — | Acute Leukemia,Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01621477Phase 2 · terminated T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant · 132 trials list this drug (9 active) | — | — | Myeloid Sarcoma,Acute Lymphoblastic Leukemia,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00824135Phase 1 · completed Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies · 132 trials list this drug (9 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00814164Phase 2 · terminated Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01960387Phase 2 · terminated Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00778375Phase 2 · completed Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) · 132 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00529360Phase 1/Phase 2 · completed Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00299156Phase 2 · completed Oral Clofarabine Study in Patients With Myelodysplastic Syndrome · 132 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00577694Phase 1 · terminated Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01295307Phase 2 · completed Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02544789Phase 2 · completed Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01065545Phase 1 · withdrawn The Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid Leukemia · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00924443Phase 2 · completed A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028418Phase 1 · completed Clofarabine in Chronic Lymphocytic Leukemia · 132 trials list this drug (9 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098033Phase 2 · completed Investigation of Clofarabine in Acute Leukemias · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Myeloid Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00337168Phase 2 · completed S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042354Phase 2 · completed Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00338494Phase 1 · completed Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma · 132 trials list this drug (9 active) | — | — | B-Cell Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00727766Phase 1 · completed Oral Clofarabine for Acute Myeloid Leukemia · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00477542Phase 1 · completed A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT · 132 trials list this drug (9 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00593645Phase 2 · terminated Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation · 132 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00477945Phase 1 · completed Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL · 132 trials list this drug (9 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132573Phase 1 · completed Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia · 132 trials list this drug (9 active) | — | — | Acute Leukemia of Ambiguous Lineage,Adult Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00315705Phase 1/Phase 2 · completed A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias. · 132 trials list this drug (9 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00317642Phase 3 · completed A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I) · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00373529Phase 2 · completed A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II) · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01193400Phase 2 · terminated Clofarabine and Low-dose Cytarabine Followed by Consolidation Therapy in AML Patients Age Greater Than or Equal to 60 Years · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00044889Phase 2 · completed Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00125827Phase 1 · completed Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors · 132 trials list this drug (9 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01090167Phase 1 · completed A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML) · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01196013Phase 1 · completed A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00724009Phase 2 · completed Clofarabine Bone Marrow Cytoreduction · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00943592Phase 1/Phase 2 · completed Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies · 132 trials list this drug (9 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00930098Phase 2 · completed A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00125840Phase 1 · completed Clofarabine in Adult Patients With Advanced Solid Tumors · 132 trials list this drug (9 active) | — | — | Solid Neoplasm,Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01500161Phase 2 · terminated Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00462787Phase 1 · completed Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia · 132 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454480Phase 2/Phase 3 · completed Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · 132 trials list this drug (9 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00241371Phase 2 · terminated A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma · 132 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00697671Phase 1 · completed Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Juvenile Myelomonocytic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00412243Phase 1/Phase 2 · completed Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients · 132 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Burkitt Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00088218Phase 2 · completed Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS). · 132 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081887Phase 1 · terminated Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia · 132 trials list this drug (9 active) | — | — | Leukemia,Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00800566Phase 1 · withdrawn Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL) · 132 trials list this drug (9 active) | — | — | Leukemia,Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00422032Phase 2 · completed 2 Arm Study of Clofarabine IV in MDS Patients · 132 trials list this drug (9 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00838240Phase 1/Phase 2 · unknown Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia · 132 trials list this drug (9 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081822Phase 1 · completed Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia · 132 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00293410Phase 1 · completed Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders · 132 trials list this drug (9 active) | — | — | Leukemia,Myelodysplastic/Myeloproliferative Neoplasm,Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |